Cite
HARVARD Citation
Castven, D. et al. (2022). Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells. Hepatology communications. 6 (5), pp. 1140-1156. [Online].